Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elevance Health ( (ELV) ) has provided an announcement.
Officers of Elevance Health said they will meet investors and analysts over the coming week and reaffirmed their 2026 adjusted shareholders’ earnings guidance of at least $25.50 per diluted share, alongside a 2026 benefit expense ratio target of 90.2% plus or minus 50 basis points. The guidance already factors in potential intermediate sanctions that the Centers for Medicare & Medicaid Services notified the company about on February 27, 2026, which could suspend Medicare Advantage-Prescription Drug enrollments and certain beneficiary communications effective March 31, 2026, and Elevance noted it cannot reasonably estimate any related financial payments under GAAP at this time.
The company emphasized that these projections remain subject to significant regulatory, operational, and market risks, including uncertainties around healthcare costs, enrollment levels, compliance with complex Medicare and Medicaid rules, technology and data security challenges, competitive pressures, and broader economic and capital markets conditions that could materially affect future performance and stakeholder outcomes.
The most recent analyst rating on (ELV) stock is a Hold with a $314.00 price target. To see the full list of analyst forecasts on Elevance Health stock, see the ELV Stock Forecast page.
Spark’s Take on ELV Stock
According to Spark, TipRanks’ AI Analyst, ELV is a Neutral.
ELV scores in the mid-range primarily due to solid underlying financial strength and attractive valuation, partially offset by deteriorating recent cash-flow/margins. The outlook is constrained by earnings-call guidance pointing to 2026 membership and profitability headwinds, and the technical picture remains weak with the stock trading below key moving averages.
To see Spark’s full report on ELV stock, click here.
More about Elevance Health
Elevance Health, Inc. is a U.S.-based health insurance and health benefits company that operates across government-sponsored and commercial programs. The company focuses on providing Medicare Advantage-Prescription Drug plans and other healthcare coverage products, positioning it as a major player in the managed care and Medicare-related insurance markets.
Average Trading Volume: 1,850,814
Technical Sentiment Signal: Sell
Current Market Cap: $61.96B
See more insights into ELV stock on TipRanks’ Stock Analysis page.